University of Applied Sciences Würzburg-Schweinfurt Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Würzburg Germany (1581)

Organization Overview

First Clinical Trial
2007
NCT00841516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bruno Allolio | Clinical Trial Center Wuerzburg | Clinical Trial Center Wuerzburg (CTCW) | Department of Neurology - University Hosiptal Würzburg | Missioklinik, Wuerzburg, Germany | Prof. Dr. med. Rak | Universitätsklinikum Würzburg | Universitätsklinikum Würzburg, CCC Mainfranken | Universitätsklinikum Würzburg, Interdisziplinäre Schmerzmedizin, Germany | Universitätsklinikum Würzburg / Medizinische Klinik und Poliklinik II | Universitätsklinikum Würzburg, Poliklinik für Zahnerhaltung und Parodontologie | University of Applied Sciences Würzburg-Schweinfurt | Werner J. Heinz

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Addison Disease (Phase 2)

Adrenal Insufficiency (Phase 2)

Gingivitis (Phase 3)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Multiple Myeloma (Phase 2)

Mycoses (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neuralgia (Phase 2)

Urogenital Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 14